Suzikem Drugs Profile
Key Indicators
- Authorised Capital ₹ 4.80 M
- Paid Up Capital ₹ 4.61 M
- Company Age 25 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.72 M
- Satisfied Charges ₹ 4.22 Cr
- Revenue Growth -53.99%
- Profit Growth -57.83%
- Ebitda -23.84%
- Net Worth 2.64%
- Total Assets 24.91%
About Suzikem Drugs
Suzikem Drugs Private Limited (SDPL) is a Private Limited Indian Non-Government Company incorporated in India on 30 June 1999 and has a history of 25 years and seven months. Its registered office is in Andhra Pradesh, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.80 M and a paid-up capital of Rs 4.61 M.
The company currently has active open charges totaling ₹1.72 M. The company has closed loans amounting to ₹4.22 Cr, as per Ministry of Corporate Affairs (MCA) records.
Kishore Bathula and Srivani Junoothula serve as directors at the Company.
Company Details
-
Location
Andhra Pradesh, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24110TG1999PTC031995
-
Company No.
031995
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
30 Jun 1999
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Suzikem Drugs?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kishore Bathula
|
Additional Director | 01-Aug-2021 | Current |
|
Srivani Junoothula
|
Additional Director | 16-Dec-2020 | Current |
Financial Performance of Suzikem Drugs.
Suzikem Drugs Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 53.99% decrease. The company also saw a substantial fall in profitability, with a 57.83% decrease in profit. The company's net worth moved up by a moderate rise of 2.64%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Suzikem Drugs?
In 2023, Suzikem Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
2D Pharmaceuticals Private LimitedKishore Bathula and Srivani Junoothula are mutual person
Charges (Loans)
₹1.72 M
₹42.19 M
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.17 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Jan 2021 | Hdfc Bank Limited | ₹1.72 M | Open |
| 29 Apr 2016 | Others | ₹1.41 Cr | Satisfied |
| 05 May 2012 | Allahabad Bank | ₹5.86 M | Satisfied |
| 22 Aug 2008 | Andhra Pradesh State Financial Corporation | ₹2.00 M | Satisfied |
| 29 Oct 2001 | Allahabad Bank | ₹2.50 M | Satisfied |
How Many Employees Work at Suzikem Drugs?
Suzikem Drugs has a workforce of 9 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Suzikem Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Suzikem Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
